Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionBridge City Capital, LLC
Latest Disclosed Ownership148,868 shares
Latest Disclosed Value $ 3,184,287
Bridge City Capital, LLC reports 0.72% decrease in ownership of PDC / Pediatrix Medical Group, Inc.

On May 13, 2026 - Bridge City Capital, LLC filed a 13F-HR form disclosing ownership of 148,868 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $2,679,624 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 149,948 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -0.72% during the quarter. The current value of the position is $2,783,832 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Pediatrix Medical Group COM 58502B106 148,868 -1,080 -0.72 3,184 -0.72 0.8825
2026-02-13 2025-12-31 13F Pediatrix Medical Group COM 58502B106 149,948 -86,981 -36.71 3,207 -19.18 0.9427
2025-11-12 2025-09-30 13F Pediatrix Medical Group COM 58502B106 236,929 88,386 59.50 3,969 86.20 1.0597
2025-08-13 2025-06-30 13F Pediatrix Medical Group COM 58502B106 148,543 -2,112 -1.40 2,132 -2.34 0.5979
2025-04-14 2025-03-31 13F MEDNAX COM 58502B106 150,655 1,794 1.21 2,183 11.73 0.6547
2025-02-11 2024-12-31 13F MEDNAX COM 58502B106 148,861 -1,562 -1.04 1,953 12.05 0.5203
2024-11-14 2024-09-30 13F MEDNAX COM 58502B106 150,423 21,445 16.63 1,743 79.14 0.4792
2024-08-13 2024-06-30 13F MEDNAX COM 58502B106 128,978 258 0.20 974 -24.63 0.3273
2024-04-12 2024-03-31 13F MEDNAX COM 58502B106 128,720 1,007 0.79 1,291 8.76 0.4703
2024-02-13 2023-12-31 13F MEDNAX COM 58502B106 127,713 15,056 13.36 1,188 -17.05 0.4601
2023-11-15 2023-09-30 13F MEDNAX COM 58502B106 112,657 32,381 40.34 1,432 25.53 0.7238
2023-08-16 2023-06-30 13F MEDNAX COM 58502B106 80,276 43 0.05 1,141 -4.68 0.5401
2023-05-15 2023-03-31 13F MEDNAX COM 58502B106 80,233 -324 -0.40 1,196 119,500.00 0.6000
2023-01-25 2022-12-31 13F MEDNAX COM 58502B106 80,557 -538 -0.66 1 -99.93 0.6142
2022-11-08 2022-09-30 13F MEDNAX COM 58502B106 81,095 2,747 3.51 1,339 -18.65 0.7348
2022-08-15 2022-06-30 13F MEDNAX COM 58502B106 78,348 -140 -0.18 1,646 -10.69 0.8707
2022-05-18 2022-03-31 13F MEDNAX COM 58502B106 78,488 -399 -0.51 1,843 -14.16 0.8611
2022-01-20 2021-12-31 13F MEDNAX COM 58502B106 78,887 -27 -0.03 2,147 -4.32 0.8853
2021-11-10 2021-09-30 13F MEDNAX COM 58502B106 78,914 -21,006 -21.02 2,244 -25.52 1.0179
2021-08-11 2021-06-30 13F MEDNAX COM 58502B106 99,920 -3,381 -3.27 3,013 14.52 1.0272
2021-04-28 2021-03-31 13F MEDNAX COM 58502B106 103,301 -1,048 -1.00 2,631 2.73 0.8721
2021-02-12 2020-12-31 13F MEDNAX COM 58502B106 104,349 -1,084 -1.03 2,561 49.24 0.9719
2020-11-16 2020-09-30 13F MEDNAX COM 58502B106 105,433 -10,243 -8.85 1,716 -13.25 0.8194
2020-07-15 2020-06-30 13F MEDNAX COM 58502B106 115,676 24,928 27.47 1,978 87.31 0.9074
2020-05-11 2020-03-31 13F MEDNAX COM 58502B106 90,748 13,041 16.78 1,056 -51.09 0.5109
2020-01-28 2019-12-31 13F MEDNAX COM 58502B106 77,707 -268 -0.34 2,159 22.39 0.8877
2019-10-22 2019-09-30 13F MEDNAX COM 58502B106 77,975 16,874 27.62 1,764 14.40 0.7595
2019-07-25 2019-06-30 13F MEDNAX COM 58502B106 61,101 285 0.47 1,542 -6.66 0.8488
2019-04-30 2019-03-31 13F MEDNAX COM 58502B106 60,816 -518 -0.84 1,652 -18.38 0.9615
2019-01-30 2018-12-31 13F MEDNAX COM 58502B106 61,334 14,342 30.52 2,024 -7.71 1.3183
2018-10-25 2018-09-30 13F MEDNAX COM 58502B106 46,992 9,232 24.45 2,193 34.21 1.3620
2018-07-23 2018-06-30 13F Mednax COM 58502B106 37,760 -1,258 -3.22 1,634 -24.74 1.0323
2018-04-26 2018-03-31 13F Mednax COM 58502B106 39,018 2,250 6.12 2,171 10.48 1.4599
2018-03-20 2017-12-31 13F Mednax COM 58502B106 36,768 0 0.00 1,965 23.97 1.4258
2017-10-30 2017-09-30 13F Mednax COM 58502B106 36,768 36,768 1,585 1.1844
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.